Dexcom | DXCM - Gewinn Vor Steuern

Aktienkurs
66.95
Täglich Wechseln
-0.32 -0.48%
Monatlich
-8.61%
Jährlich
-9.28%
Q1 Prognose
62.30




Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.36B 178M 2025-12
Align Technology USD 176.6M 81.86M 2025-12
AtriCure USD 2.36M 2.45M 2025-12
Avanos Medical USD -1.2M 74.7M 2025-09
Baxter International USD 121M 12M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 938M 3M 2025-09
Cooper Companies USD 116.8M 137.4M 2025-09
Dexcom USD 300M 58.9M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
Hologic USD 229.7M 2.3M 2025-12
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
J&J USD 4.97B 2.53B 2025-12
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 73.18M 29.8M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Solventum Corp USD 511M 149M 2025-09
Stryker USD 1.03B 13M 2025-09
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
West Pharmaceutical Services USD 170.1M 8.1M 2025-09
Zimmer Biomet Holdings USD 418.7M 194.1M 2025-09